Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Plasma adrenomedullin level and development of hypertension

Journal of Human Hypertension volume 20, pages 566–570 (2006)Cite this article

Abstract

The hypotensive peptide adrenomedullin (AM) is assumed to act as a factor inhibitory on elevation of blood pressure and on progression of the hypertensive organ damage, and plasma AM levels are elevated in patients with hypertension. The aim of the present study is to explore whether or not a rise in plasma AM levels precedes the development of hypertension. Normotensive local residents without apparent cardiovascular or renal disease (n=177) were divided into low and high AM groups based on the median concentration of AM in plasma (11.9 fmol/ml), and followed up for 3 years for development of hypertension. The incidence of hypertension was higher in the residents with high AM than low AM levels (27.8 vs 11.5%, P<0.01), whereas a similar analysis of plasma levels of atrial or brain natriuretic peptides revealed no such difference. The plasma AM level was found to be a significant parameter for the development of hypertension in a univariate analysis (P<0.01), but not in a multivariate analysis. Meanwhile, the plasma AM level was significantly (P<0.01) correlated with age and body mass index (BMI), two variables independently significant for the development of hypertension. The present findings suggest that an elevation of the plasma AM level associated with aging and increased BMI precedes the development of hypertension in the normotensive subjects.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commum 1993; 192: 553–560.

    Article  CAS  Google Scholar 

  2. Kato J, Tsuruda T, Kitamura K, Eto T . Adrenomedullin: a possible autocrine or paracrine hormone in the cardiac ventricles. Hypertens Res 2003; 26 (Suppl): S113–S119.

    Article  CAS  Google Scholar 

  3. Kato J, Tsuruda T, Kita T, Kitamura K, Eto T . Adrenomedullin: a protective factor for blood vessels. Arterioscler Thromb Vasc Biol 2005; 25: 2480–2487.

    Article  CAS  Google Scholar 

  4. Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 1994; 94: 2158–2161.

    Article  CAS  Google Scholar 

  5. Kato J, Kobayashi K, Etoh T, Tanaka M, Kitamura K, Imamura T et al. Plasma adrenomedullin concentration in patients with heart failure. J Clin Endocrinol Metab 1996; 81: 180–183.

    CAS  PubMed  Google Scholar 

  6. Suzuki Y, Horio T, Hayashi T, Nonogi H, Kitamura K, Eto T et al. Plasma adrenomedullin concentration is increased in patients with peripheral arterial occlusive disease associated with vascular inflammation. Regul Pept 2004; 118: 99–104.

    Article  CAS  Google Scholar 

  7. Shindo T, Kurihara Y, Nishimatsu H, Moriyama N, Kakoki M, Wang Y et al. Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 2001; 104: 1964–1971.

    Article  CAS  Google Scholar 

  8. Shimosawa T, Shibagaki Y, Ishibashi K, Kitamura K, Kangawa K, Kato S et al. Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 2002; 105: 106–111.

    Article  CAS  Google Scholar 

  9. Tsuruda T, Kato J, Hatakeyama K, Masuyama H, Cao YN, Imamura T et al. Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats. Cardiovasc Res 2005; 65: 921–929.

    Article  CAS  Google Scholar 

  10. Kato J, Eto T . Natriuretic peptides. In: Martini L, ed Encyclopedia of Endocrine Diseases. Academic Press: San Diego, 2004 pp 287–290.

    Chapter  Google Scholar 

  11. Kato J, Etoh T, Kitamura K, Eto T . Atrial and brain natriuretic peptides as markers of cardiac load and volume retention in primary aldosteronism. Am J Hypertens 2005; 18: 354–357.

    Article  CAS  Google Scholar 

  12. Ohta H, Tsuji T, Asai S, Tanizaki S, Sasakura K, Teraoka H et al. A simple immunoradiometric assay for measuring the entire molecules of adrenomedullin in human plasma. Clin Chim Acta 1999; 287: 131–143.

    Article  CAS  Google Scholar 

  13. Pousset F, Masson F, Chavirovskaia O, Isnard R, Carayon A, Golmard JL et al. Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure. Eur Heart J 2000; 21: 1009–1014.

    Article  CAS  Google Scholar 

  14. Nagaya N, Nishikimi T, Uematsu M, Yoshitomi Y, Miyao Y, Miyazaki S et al. Plasma adrenomedullin as an indicator of prognosis after acute myocardial infarction. Heart 1999; 81: 483–487.

    Article  CAS  Google Scholar 

  15. Kato J, Kitamura K, Uemura T, Kuwasako K, Kita T, Kangawa K et al. Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure. Hypertens Res 2002; 25: 887–892.

    Article  CAS  Google Scholar 

  16. Letizia C, Iacobellis G, Caliumi C, Leonetti F, Cotesta D, Ribaudo MC et al. Acute hyperinsulinemia is associated with increased plasma adrenomedullin concentrations in uncomplicated obesity. Exp Clin Endocrinol Diabetes 2005; 113: 171–175.

    Article  CAS  Google Scholar 

  17. Nambu T, Arai H, Komatsu Y, Yasoda A, Moriyama K, Kanamoto N et al. Expression of the adrenomedullin gene in adipose tissue. Regul Pept 2005; 132: 17–22.

    Article  CAS  Google Scholar 

  18. Li Y, Totsune K, Takeda K, Furuyama K, Shibahara S, Takahashi K . Differential expression of adrenomedullin and resistin in 3T3-L1 adipocytes treated with tumor necrosis factor-α. Eur J Endocrinol 2003; 149: 231–238.

    Article  CAS  Google Scholar 

  19. Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO, Harris BC et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 2004; 43: 1590–1595.

    Article  CAS  Google Scholar 

  20. Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 2005; 112: 2163–2168.

    Article  CAS  Google Scholar 

  21. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509–516.

    Article  CAS  Google Scholar 

  22. Arakawa N, Nakamura M, Aoki H, Hiramori K . Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 1996; 27: 1656–1661.

    Article  CAS  Google Scholar 

  23. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350: 655–663.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The present study was partly supported by Grants-in-aid for Scientific Research and for the 21st Century COE Program (Life Science) from MEXT, Japan.

Author information

Authors and Affiliations

  1. First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Kiyotake, Miyazaki, Japan

    J Kato, K Kitamura & T Eto

Authors
  1. J Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Kitamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Eto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J Kato.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kato, J., Kitamura, K. & Eto, T. Plasma adrenomedullin level and development of hypertension. J Hum Hypertens 20, 566–570 (2006). https://doi.org/10.1038/sj.jhh.1002033

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1002033

Keywords

This article is cited by

Search

Advanced search

Quick links